These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 15730535
1. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine. Britzi M, Perucca E, Soback S, Levy RH, Fattore C, Crema F, Gatti G, Doose DR, Maryanoff BE, Bialer M. Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535 [Abstract] [Full Text] [Related]
2. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Mimrod D, Specchio LM, Britzi M, Perucca E, Specchio N, La Neve A, Soback S, Levy RH, Gatti G, Doose DR, Maryanoff BE, Bialer M. Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556 [Abstract] [Full Text] [Related]
3. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Sachdeo RC, Sachdeo SK, Walker SA, Kramer LD, Nayak RK, Doose DR. Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818 [Abstract] [Full Text] [Related]
4. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Doose DR, Wang SS, Padmanabhan M, Schwabe S, Jacobs D, Bialer M. Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003 [Abstract] [Full Text] [Related]
5. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation. Bialer M, Shekh-Ahmad T, Braun TL, Halvorsen MB. Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553 [Abstract] [Full Text] [Related]
6. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Shank RP, Doose DR, Streeter AJ, Bialer M. Epilepsy Res; 2005 Feb; 63(2-3):103-12. PubMed ID: 15715969 [Abstract] [Full Text] [Related]
8. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects. Nunes T, Sicard E, Almeida L, Falcão A, Rocha JF, Brunet JS, Lefebvre M, Soares-da-Silva P. Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319 [Abstract] [Full Text] [Related]
11. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers. Clark AM, Kriel RL, Leppik IE, Marino SE, Mishra U, Brundage RC, Cloyd JC. Epilepsia; 2013 Jun; 54(6):1099-105. PubMed ID: 23506041 [Abstract] [Full Text] [Related]
17. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. Krauwinkel W, van Dijk J, Schaddelee M, Eltink C, Meijer J, Strabach G, van Marle S, Kerbusch V, van Gelderen M. Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375 [Abstract] [Full Text] [Related]